In the clinic, total B cells are being eliminated using CD19 chimeric antigen receptor (CAR) T cells in patients with systemic lupus erythematosus and other autoimmune disorders, leading to disease remission (44, 45). The gene discussed is CD19; the disease is systemic lupus erythematosus.